Advances in haemapheresis: Proceedings of the Third International Congress of the World Apheresis Association. April 9–12,1990, Amsterdam, The Netherlands
Cees Smit Sibinga, L. Kater
Springer Science & Business Media, Jul 31, 1991 - Medical - 270 pages
The first International Meeting on Apheresis was held in Dyon in 1984. At the congress it became clear that both the technical and therapeutic sides developed very rapidly and it appeared fruitful to bring together the investigators of the different countries working in the areas. At that time immunology had come to pervade many clinical specialities, and hemapheresis, especially plasmapheresis was considered a therapeutic tool in many immunological diseases which hitherto had proved to be fatal. New methods to identify certain antibodies and circulating immune complexes in the serum and the possibilities to remove them from the blood by several techniques (filtration, centrifugation, immunoabsorp tion) led to an almost uncontrolled use of plasma exchange in a variety of diseases. Since then the technical possibilities of this technique were further recognized, as was the impact of immunology on many diseases, and the possibilities to collect specific components for therapeutic pur poses. But also we became aware of the limited contributions of anec dotal data on successes or failures of apheresis as adjuvant treatment. Therefore international prospective studies were initiated to make critical assessment possible of apheresis in various diseases.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Centrifugation versus filtration
The advantages of centrifugation in therapeutic plasmapheresis
High performance systems for membrane plasmapheresis
Two year clinical experience using a rotating filter for therapeutic plasma exchange
Donor plasmapheresis technology
Plasma exchange in peripheral neuropathy
Plasma exchange and GuillianBarre syndrome
Are immunoglobins superior to plasma exchange in the GuillainBarre syndrome?
Peripheral blood stem cell transplants in myeloma
High dose chemotherapy and blood stem cell autologou graft in multiple myeloma
A new perspective
A perspective for hematopoietic growth factors
Immunotherapy for hematological malignancies
The promise of T cell immunotherapy of cancer
A new approach to the management of Tcell mediated disorders
High levels of circulating hematopoietic progenitor cells after continuous infusion of high dose interleukin2 in cancer patients
Plasmapheresis in neurological disorder
The value of plasma exchange
Autologous transplantation of blood versus marrow derived hemopoietic stem cells
Granulocyte macrophage progenitor numbers in perpheral blood stem cell autotransplantation
Better or worse than circulating stem cells?
Purification and clinical results
Collection and transplantation of peripheral hemopoietic stem cells Results in 35 patients with hematological and nonhematological malignancies
Is leukocyte depletion important in the prevention of alloimmunization by random single donor platelet transfusion?
Effects on the immune system and on platelet function viability and alloimmunization
Elutriated single versus pooled donor platelets
Platelet concentrates from buffy coats
Selection of platelet apheresis donors for alloimmunized patients by ELISA platelet crossmatch versus HLAmatching
Other editions - View all
ABMT ABSCT activity acute leukemia allogeneic alloimmunization antibodies antigen apheresis autograft autologous bone marrow BC-PC blood cells blood stem cell bone marrow transplantation cancer centrifugation chemotherapy chronic clinical clones collection cord blood cyclophosphamide cytotoxic demyelinating disease donor platelets effect engraftment factors Fenwal filter filtration function graft granulocytes Guillain-Barré syndrome Haematol Haemonetics hematological hematopoietic hemopoietic reconstitution hemopoietic stem cells high dose HLA-matched human immune Immunol immunosuppressive induced infusion interleukin-2 Juttner Lancet leukapheresis leukocyte lymphocytes lymphoma malignant median membrane mononuclear cells multiple myeloma multiple sclerosis myelin myeloid Neurol Neurology patients PBSC peripheral blood stem photopheresis plasma exchange plasmapheresis platelet concentrates platelet counts platelet transfusions progenitor cells protein PRP-PC random randomisation recovery red cells refractory reinfusion relapse remission stem cells storage T-cells therapeutic therapy tion trans treatment trial tumor cells ultraviolet UV-B UV-irradiated vitro vivo whole blood